Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination. (2023)

First Author: Zaloum SA
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/13524585231185247

PubMed Identifier: 37431627

Publication URI: http://europepmc.org/abstract/MED/37431627

Type: Journal Article/Review

Volume: 29

Parent Publication: Multiple sclerosis (Houndmills, Basingstoke, England)

Issue: 8

ISSN: 1352-4585